El-Hamamsy Ismail, Cartier Raymond, Demers Philippe, Bouchard Denis, Pellerin Michel
Department of Cardiovascular Surgery, Montreal Heart Institute, 5000 Belanger St, Montreal, Quebec H1T 1C8, Canada.
Circulation. 2006 Jul 4;114(1 Suppl):I486-91. doi: 10.1161/CIRCULATIONAHA.105.001651.
Off-pump coronary artery bypass surgery (OPCAB) is currently used as an alternative to conventional "on-pump" surgery, but there are very little data available on long-term follow-up. The aim of this study was to review our long-term experience with the use of systematic OPCAB.
1000 consecutive OPCAB surgeries were systematically performed between 1996 and 2004, representing 95% of all coronary revascularization during that same time frame, with a 97% complete follow-up. Average age of the patients was 64+/-10 years (778 men and 222 women). Seventy-three percent had triple-vessel disease. Operative 30-day mortality was 1.6%. Overall survival at 96 months was 74+/-3.5% and cardiac survival was 94+/-1.3%. By Cox regression analysis, age (odds ratio [OR], 1.07), congestive heart failure (CHF) (OR, 1.90), peripheral vascular disease (OR, 1.74), chronic renal insufficiency (OR, 2.04), previous myocardial infarction (MI) (OR, 1.60), and New York Heart Association functional class (OR, 1.60) were risk factors for long- term mortality. Survival free of any cardiac events (cardiac death, MI, unstable angina, heart failure, or reintervention) was 80+/-3.4%. Survival free of any type of reintervention alone was 90+/-3%. By Cox regression analysis, mitral regurgitation (OR, 2.3), peripheral vascular disease (OR, 2.1), and diffuse coronary disease (OR, 2.3) were significant predictors of recurrent cardiac events. Conversion to "on-pump" (OR, 14.3) was predictor of long-term need for repeat revascularization.
In this series, systematic OPCAB surgery was shown to be an acceptable alternative to conventional "on-pump" coronary artery bypass graft for the treatment of coronary artery disease.
非体外循环冠状动脉搭桥手术(OPCAB)目前被用作传统“体外循环”手术的替代方法,但关于长期随访的数据非常少。本研究的目的是回顾我们使用系统性OPCAB的长期经验。
1996年至2004年间系统地进行了1000例连续的OPCAB手术,占同一时期所有冠状动脉血运重建手术的95%,随访完整率为97%。患者的平均年龄为64±10岁(778例男性和222例女性)。73%的患者患有三支血管病变。手术30天死亡率为1.6%。96个月时的总体生存率为74±3.5%,心脏生存率为94±1.3%。通过Cox回归分析,年龄(比值比[OR],1.07)、充血性心力衰竭(CHF)(OR,1.90)、外周血管疾病(OR,1.74)、慢性肾功能不全(OR,2.04)、既往心肌梗死(MI)(OR,1.60)和纽约心脏协会功能分级(OR,1.60)是长期死亡率的危险因素。无任何心脏事件(心脏死亡、MI、不稳定型心绞痛、心力衰竭或再次干预)的生存率为80±3.4%。仅无任何类型再次干预的生存率为90±3%。通过Cox回归分析,二尖瓣反流(OR,2.3)、外周血管疾病(OR,2.1)和弥漫性冠状动脉疾病(OR,2.3)是心脏事件复发的显著预测因素。转为“体外循环”(OR,14.3)是长期需要再次血运重建的预测因素。
在本系列研究中,系统性OPCAB手术被证明是治疗冠状动脉疾病的传统“体外循环”冠状动脉搭桥术的可接受替代方法。